文献速递睡眠呼吸障碍

OSA治疗:CPAP之外的治疗选择

Treating OSA: Current and emerging therapies beyond CPAP.
PubMed 文献 · Respirology · 2017-09-12

持续气道正压通气(CPAP)是中重度阻塞性睡眠呼吸暂停(OSA)的标准治疗,但依从性有限。本文综述了口腔矫治器、上气道刺激、口咽训练、鼻呼气相正压及Winx等非CPAP疗法的疗效与局限。

要点

  • 口腔矫治器疗效劣于CPAP,但改善嗜睡、生活质量等效果相似。
  • 上气道刺激(STAR研究)使OSA严重度降低68%,但费用高且反应不一。
  • 口咽训练、鼻EPAP及Winx装置对部分OSA患者有效。

核心结论

  • 多种非CPAP疗法可用于治疗OSA,口腔矫治器、上气道刺激、口咽训练、鼻EPAP及Winx各有其适用人群与局限。

研究设计与样本

  • 综述性文章,汇总非CPAP疗法治疗OSA的研究证据,包括STAR研究(n=126)、口咽训练试验(n=120)、鼻EPAP系统评价(n=345)等。

主要发现

  • 口腔矫治器疗效劣于CPAP,但以嗜睡、生活质量、内皮功能及血压衡量的效果相似,可能因其接受度和主观依从性更高。
  • 上气道刺激通过单侧刺激舌下神经增强神经驱动,STAR研究显示OSA严重度降低68%。
  • 口咽训练可改善OSA和打鼾约30-40%。
  • 鼻EPAP系统评价显示OSA严重度降低53%。
  • Winx装置可能为约30-40%的OSA患者提供成功治疗。

关键数值与推荐

  • STAR研究纳入126例患者,OSA严重度降低68%。
  • 口咽训练汇总试验(n=120)显示可改善OSA和打鼾约30-40%。
  • 鼻EPAP系统评价(n=345)显示OSA严重度降低53%。
  • Winx可能对约30-40%的OSA患者有效。

临床怎么用

  • 对于CPAP依从性不佳的OSA患者,可评估口腔矫治器、上气道刺激、口咽训练、鼻EPAP或Winx等非CPAP疗法。
  • 选择非CPAP疗法时需考虑疗效、费用、患者偏好及反应差异。

局限性

  • 上气道刺激的高 upfront 费用和可变反应是主要限制。
  • 口腔矫治器疗效劣于CPAP。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Continuous positive airway pressure (CPAP) is the standard treatment for moderate-to-severe obstructive sleep apnoea (OSA). However, adherence to CPAP is limited and non-CPAP therapies are frequently explored. Oral appliance (OA) therapy is currently widely used for the treatment of snoring, mild, moderate and severe OSA. The most commonly used and studied OA consists of a maxillary and mandibular splint which hold the lower jaw forward during sleep. The efficacy of OA is inferior to CPAP; however, the effectiveness as measured by sleepiness, quality of life, endothelial function and blood pressure is similar likely due to higher acceptance and subjective adherence. Upper airway stimulation augments neural drive by unilaterally stimulating the hypoglossal nerve. The Stimulation Therapy for Apnea Reduction (STAR) study enrolled 126 patients and demonstrated a 68% reduction in OSA severity. A high upfront cost and variable response are the main limitations. Oropharyngeal exercises consist of a set of isometric and isotonic exercises involving the tongue, soft palate and lateral pharyngeal wall. The collective reported trials (n = 120) showed that oropharyngeal exercises can ameliorate OSA and snoring (~30-40%). Nasal EPAP devices consist of disposable one-way resister valve. A systematic review (n = 345) showed that nasal EPAP reduced OSA severity by 53%. The Winx device consists of a mouthpiece placed inside the oral cavity that is connected by tubing to a console that generates negative pressure. Winx may provide successful therapy for ~30-40% of OSA patients. In conclusion, several non-CPAP therapies to treat OSA are currently available.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Lorenzi-Filho G, Almeida FR, Strollo PJ, et al. Treating OSA: Current and emerging therapies beyond CPAP. Respirology. 2017. PMID: 28901030. doi:10.1111/resp.13144

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。